FDA Investigator Hurst
Hurst has inspections in 1 countries as of 24 Aug 2023. Hurst has collaborated with a combined 1793 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
90
Last Inspection Date:
24 Aug 2023
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adam C Hipko,
Alcee M Tavarez,
Angela Mock,
Ashley N Williams,
Betsy C Galliher,
Bing Lin,
Blondell W Johnson,
Brenda G Stewart Munoz,
Carol A Declouette Wilburn,
Casey L Hamblin,
Cassandra L Abellard,
Cathleen A Castellaw,
Charles B Steinmiller,
Charles D Brown,
Christopher D Rush,
Christopher J Hurst,
Christopher J Smith,
Christopher K Gibbs,
Christopher L Jacobs,
Connie L Hannon Rabel,
Constance M Dobbins,
Dallas E Gilbreath Jr,
Dana M Lewis,
Daniel J Lahar,
Daniel S Fam,
Danielle Lyke,
Danny D Horner,
Darla J Christopher,
David Castillo,
Dawn P Hall,
Deniza Karacic,
Ed Gonzalez Vazquez,
Elisa M Fleming,
Elkins,
Elmina E Akwo,
Elmina E Mboh,
Emilio O Escobar,
Ernest Serna, III,
Florecia S Philogene,
Frans E Mercado,
Gery M Duparc,
Grant L Davis,
Gregory A Holt,
Hudson,
Hung V Le,
Jacob S Foster,
Jacob W Reynolds,
Jamie M Bumpas,
Janice M Hickok,
Jeffrey R Wooley,
Jeremy R Read,
Jocelyn C Turner,
Johann M Fitch,
John Ahearn,
Johnson,
Jonathan A Womack,
Joseph B Carballa,
Joy L Ramsey,
Kari M Johansen,
Karlton T Watson,
Kunapuli T Madhusudhan,
Lauren E Skokan,
Leighton K Ngai,
Lisa M Puttonen,
Lisa R Jennings,
Lorie S Hannappel,
Lourdes R Genera,
Mario Seminara,
Mark C Flotte,
Martha S Baldwin,
Monique Rac Lester,
Nathan D Livers,
Ninfa N Innocent,
Patrick D Stone, MS,
Paul E Frazier,
Paulene M Wohlgemuth,
Pauline N Logan,
Philip M Steele, PhD,
Rebecca C O Bryan,
Regina D Hunt,
Rene R Ramirez,
Rhonda L Dash,
Rian L Pope,
Robert M Tillman,
Robert T Harris,
Robert T Lorenz,
Rodriguez,
Ronnie Garza,
Roy Baby,
Saijal P Naik,
Scott A Hendrix,
Selina M Mata,
Shannon A Lowe,
Staci G Mcallister,
State Agency,
Steven L Strom,
Susan C Baltzer,
Tamera H Hunt,
Thomas Martinez,
Timothy B Webb,
Toby Vern H Hill,
Tricia S Martinez,
Trina K Vick,
Trinidad D Barreras,
Yaw O Osei
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more